VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1811371
Sex: F
Age:
State: PA

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Severe Tinnitus; Chronic fatigue; This is a spontaneous report from a contactable other health care professional, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER1734) via an unspecified route of administration in the left arm on 09Apr2021 at 20:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received pethidine hydrochloride (DEMEROL) for unspecified indication from unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER7534) via an unspecified route of administration on the left arm on 19Mar2021 at 20:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. On 10Apr2021, the patient experienced severe tinnitus and chronic fatigue. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe tinnitus and chronic fatigue was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811372
Sex: F
Age:
State: CA

Vax Date: 04/22/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210425; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Diarrhea; Vomiting; Fever; Muscle pain; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration on 22Apr2021 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced diarrhea, vomiting, fever, muscle pain and joint pain. On 25Apr2021, the patient underwent nasal swab test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events diarrhea, vomiting, fever, muscle pain and joint pain was recovering at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811373
Sex: M
Age:
State: GA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210422; Test Name: Body temperature; Result Unstructured Data: Test Result:101.8

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Sore muscles; Aching joints; Congestion; Sore back; Fever (101.8 was the highest reading); Constant tiredness; Inability to sleep at night; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0158) via an unspecified route of administration in the left arm on 21Apr2021 at 20:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the left arm on 31Mar2021 at 19:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. On 22Apr2021 at 09:00, the patient experienced sore muscles, aching joints, congestion, sore back, fever (101.8 was the highest reading), constant tiredness and inability to sleep at night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events sore muscles, aching joints, congestion, sore back, fever (101.8 was the highest reading), constant tiredness and inability to sleep at night were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811374
Sex: F
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Full body rash that was very itchy; Fever; Chills; Headache; Body ache; Nausea; Loss of appetite; Severe pain in left arm at injection site, causing inability to raise arm for 2 days; Severe pain in left arm at injection site, causing inability to raise arm for 2 days; This is a spontaneous report from a non-contactable consumer, the patient. A 63-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to non-steroidal anti-inflammatory drugs (NSAIDs). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 23Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient also previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 13Apr2021 (reported as 4 to 48 hours post vaccine), the patient experienced fever, chills, headache, body ache, nausea and loss of appetite. The patient also experienced severe pain in left arm at injection site, causing inability to raise arm for 2 days. On 15Apr2021, 2 days post vaccine, the patient experienced full body rash that was very itchy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events full body rash that was very itchy, fever, chills, headache, body ache, nausea, loss of appetite and severe pain in left arm at injection site, causing inability to raise arm for 2 days was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811375
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 03/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Severe dizziness; Ringing in ears; Brain fog; Trouble concentrating; Fatigue; Nausea; Headaches; Tingling in fingers; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 04 Mar2021 at 09:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient previously took trimethobenzamide hydrochloride (TIGAN) and experienced drug allergy. On 25Mar2021 the patient experienced severe dizziness, ringing in ears, brain fog, trouble concentrating, fatigue, nausea, headaches, tingling in fingers and swollen lymph nodes. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe dizziness, ringing in ears, brain fog, trouble concentrating, fatigue, nausea, headaches, tingling in fingers and swollen lymph nodes was not resolved at the time of this report. . No follow-up attempts are needed. No further information is expected .

Other Meds:

Current Illness:

ID: 1811376
Sex: F
Age:
State: MO

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Tinnitus; Diarrhea; Shortened menstrual cycle; This is a spontaneous report from a contactable healthcare professional, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 26Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 27Mar2021, the patient experienced tinnitus, diarrhoea and shortened menstrual cycle. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tinnitus, diarrhoea and shortened menstrual cycle was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811377
Sex: M
Age:
State: MD

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Injection site pain; Tiredness; Muscle pain; Joint pain/weakness; Joint tightness; Chills; Loss of appetite; joint pain/weakness; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 11:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 23Apr2021 at 05:00 the patient experienced injection site pain, tiredness, muscle pain, joint pain/weakness, joint tightness, chills and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, tiredness, muscle pain, joint pain/weakness, joint tightness, chills and loss of appetite was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811378
Sex: M
Age:
State:

Vax Date:
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Fever; Chills; Aches; This is a spontaneous report from a non-contactable consumer. An 18-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Apr2021, the patient experienced fever, chills and aches. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills and aches were resolved on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811379
Sex: F
Age:
State: FL

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Tightness and pain in calves; Pain in calves; Calves very swollen and painful to touch; Facial swelling; Painful to touch, painful to walk and painful to rest legs on pillows.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration on 23Apr2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to soy, lactose, beans, pork and corn. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine Concomitant medications included paracetamol (TYLENOL), tilactase (LACTAID) and loratadine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 24Apr2021, the patient experienced tightness and pain in calves. The patient's calves were very swollen and painful to touch, painful to walk and painful to rest her legs on pillows. The patient had some facial swelling. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events tightness and pain in calves, calves were very swollen, painful to touch, painful to walk and painful to rest her legs on pillows and some facial swelling were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; LACTAID; LORATADINE

Current Illness:

ID: 1811380
Sex: F
Age:
State: MA

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: got skin rashes all over the body; This is a spontaneous report from a contactable consumer. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0175) via an unspecified route of administration in the left arm on 23Apr2021 at 11:15 at the age of 51-years-old as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included VITAMIN D, TRIVORA, and Multivitamins, all taken for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, the day after the first shot, the patient experienced skin rashes all over the body except the face that looked like chicken pox not itchy though. She had chicken pox, when she was under 6-year-old and never been vaccinated for it. The patient had no fever and was less active on second day, but still there and less visible with no blood or scar. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event got skin rashes all over the body was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D; TRIVORA

Current Illness:

ID: 1811381
Sex: F
Age:
State: MA

Vax Date: 04/22/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: 48 hours after vaccinestarted getting headache; Rash on hip; Terrible migraine; Throwing up; Delayed response; Felt a little sick; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Fb-er8735) via an unspecified route of administration in the left arm on 22Apr2021 at 17:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. The patient did not receive any vaccination within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: F-ep7533) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 17:00, the patient experienced delayed response, felt little sick, felt better, rash on hip and terrible migraine, throwing up and then 48 hours after vaccine started getting headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events delayed response, felt little sick, felt better, then 48 hours after vaccine started getting headache, rash on hip and terrible migraine and throwing up were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811382
Sex: F
Age:
State: IL

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Chills; Fever; Headache; Vomiting; Diarrhea; Dizziness; This is a spontaneous report from a contactable consumer. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0169) via an unspecified route of administration in the arm left on 22Apr2021 at 11:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication taken within two weeks of vaccination was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 30Mar2021 at 11:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 23:30, the patient experienced chills, fever, headache, vomiting, diarrhea and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, headache, vomiting, diarrhea and dizziness was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811383
Sex: F
Age:
State: TN

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Injection site pain; Arm pain; Tiredness; Headache; Muscle pain; Joint pain; Nausea; Vomiting; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 09:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, and adhesive allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received unspecified medication within two weeks of vaccination. On 09Apr2021 at 17:00, the patient experienced injection site pain and arm pain, tiredness, headache, muscle pain, joint pain, nausea and vomiting, diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain and arm pain, tiredness, headache, muscle pain, joint pain, nausea and vomiting, diarrhea were resolved on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811384
Sex: F
Age:
State:

Vax Date: 04/10/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Pain measurement; Result Unstructured Data: Test Result:8/10; Test Name: Pain measurement; Result Unstructured Data: Test Result:2/10

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Less bleeding than normal; Extreme menstrual cramping my cramps are usually 2/10 but I experienced about 8/10 pain; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine headache, latex allergy and allergic bananas. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol/norgestimate (TRINESSA) for birth control and vitamins nos (DAILY VITAMINS) used for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 22:00, the patient had extreme menstrual cramping. The patient cramps are usually 2/10 but experienced about 8/10 pain. Went to the doctor thinking the patient was having an apendicitus, all medical tests done came back healthy. The pain began 3 days before patient took blank pill, period came at a normal time (5 days after the pain began) with less bleeding than normal on 21Apr2021. The patient was currently on the last day of cycle and the pain was still debilitating. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme menstrual cramping and less bleeding than normal were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: TRINESSA; DAILY VITAMINS

Current Illness:

ID: 1811385
Sex: M
Age:
State: CA

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Got a pretty strong nose bleed from both nostrils; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 16:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 24Apr2021 at 22:30 (also reported as 22:00), 30 hours after the injection, the patient got a pretty strong nose bleed from both nostrils. And then again 47 hours after injection. The event did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measure was not taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pretty strong nose bleed from both nostrils was unknown at the time of this vaccination. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811386
Sex: M
Age:
State: NY

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Dose 1: 29Mar2021; dose 2: 08Apr2021; Severe tinnitus; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 17:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 17:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication was not reported. On 30Mar2021 at 04:00, the patient experienced severe tinnitus. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe tinnitus was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811387
Sex: F
Age:
State: TX

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: On the morning of 4/23 around 12:30am, I began to develop flu-like symptoms; Body aches; Fever; Chills; Mild headache; I had terrible joint pain as well in my elbows, wrists, ankles, and my knees. It was most severe in my knees. They throbbed consistently.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 22Apr2021 at 11:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included kawasaki's disease in 2002, latex allergy, allergy to nickel and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fluoxetine (MANUFACTURER UNKNOWN) and ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN); both for unknown indicatiion on unknown date and unknown if ongoing. The patient previously took cefaclor (CECLOR) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On the morning of 23Apr2021 around 00:30, the patient began to develop flu-like symptoms. The patient had body aches, fever, chills and a mild headache. The patient had terrible joint pain as well in her elbows, wrists, ankles, and her knees. It was most severe in her knees. They throbbed consistently. It hurt to stand. Her symptoms continued for about 36 hours. The patient no longer had them. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL), which somewhat alleviated her symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events began to develop flu-like symptoms; had body aches, fever, chills and a mild headache; had terrible joint pain as well in her elbows, wrists, ankles, and her knees; it was most severe in her knees; they throbbed consistently; it hurt to stand. Her symptoms continued for about 36 hours was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: FLUOXETINE; ORTHO TRI-CYCLEN

Current Illness:

ID: 1811388
Sex: F
Age:
State: GA

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: The afternoon following the 2nd vaccine i broke out in hives and started itching. From the bottom of my feet to my neck. My legs, arms, back, stomach, hands. This went on for 4 days straight. It got worse in the evenings and at night; The afternoon following the 2nd vaccine i broke out in hives and started itching. From the bottom of my feet to my neck. My legs, arms, back, stomach, hands. This went on for 4 days straight. It got worse in the evenings and at night; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 12Apr2021 at 11:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included cardiomyopathy, congestive heart failure and left bundle branch block. The patient had known allergies to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications; taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 22Mar2021 at 11:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient previously received iodine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 12Apr2021 at 15:00, the afternoon following the second vaccine, the patient experienced break out in hives and started itching. From the bottom of her feet to neck. Her legs, arms, back, stomach, hands. This went on for 4 days straight. It got worse in the evenings and at night. It slacked off for a few days and started back up. It was so unbearable that she had to go to the emergency room. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with 3 different medications which were unspecified. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the afternoon following the second vaccine the patient had break out in hives and started itching from the bottom of her feet to her neck, legs, arms, back, stomach, hands, this went on for 4 days straight and it got worse in the evenings and at night was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811389
Sex: M
Age:
State: AL

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Sore arm; Fatigue; Flu-like symptoms; Low grade fever; This is a spontaneous report from a contactable consumer. A 77-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on an unknown date in Mar2021 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on an unknown date in Mar2021 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Mar2021, the patient experienced sore arm, fatigue, flu-like symptoms, low grade fever for several days after second dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the events sore arm, fatigue, flu-like symptoms, low grade fever were recovered on an unknown date in 2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811390
Sex: F
Age:
State: GA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210417; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Have lost my sense of taste and smell.; Have lost my sense of taste and smell.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021, the patient experienced loss of sense of taste and smell. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 17Apr2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the event loss of sense of taste and smell was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811391
Sex: F
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Large growing rash that is hot to touch sore and spreading; Large growing rash that is hot to touch sore and spreading; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 14:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021, the patient experienced large growing rash that was hot to touch sore and spreading. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events large growing rash that was hot to touch sore and spreading were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811392
Sex: F
Age:
State:

Vax Date: 04/14/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Itchy rash around injection site, roughly 2 sq inches in size.; Itchy rash around injection site, roughly 2 sq inches in size.; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 14Apr2021 at 11:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included norethisterone acetate, ethinylestradiol, ferrous fumarate (AUROVELA FE 1/20) taken for unknown indication, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 15Mar2021 at 12:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 20Apr2021 at 01:30 the patient experienced itchy rash around injection site, roughly 2 square inches in size. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event itchy rash around injection site, roughly 2 square inches in size was not recovered at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds: AUROVELA FE 1/20

Current Illness:

ID: 1811393
Sex: F
Age:
State: TX

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210109; Test Name: Antibodies; Test Result: Negative ; Comments: Blood test

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Broke out in hives 24 hrs later in the warms areas of body neck, behind knees, inner side of elbow, under arms, thighs, stomach and below buttocks; My lips, eyes, ears and feet swelled up; My lips, eyes, ears and feet swelled up; My lips, eyes, ears and feet swelled up; My lips, eyes, ears and feet swelled up; This is a spontaneous report from a contactable consumer (patient). A 46-yearsold non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 20Apr2021 17:15 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The vaccine was administered at public health facility. Medical history included sinuses. Concomitant medications included tizanidine; beta vulgaris, folic acid, malus spp. vinegar extract, punica granatum, vitamin b12 nos (GOLI); antibiotics; vitamins, all taken for an unspecified indication, start and stop date were not reported. On 21Apr2021 17:30, the patient experienced broke out in hives 24 hrs later in the warms areas of body neck, behind knees, inner side of elbow, under arms, thighs, stomach and below buttocks; my lips, eyes, ears and feet swelled up. The events required a visit to the physician's office. Therapeutic measures were taken as a result of the events included a steroid shot plus 5 days of oral meds prednisone. The outcome of the events was recovering. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 09Jan2021 (Blood test). The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: TIZANIDINE; GOLI

Current Illness:

ID: 1811394
Sex: M
Age:
State: CA

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20201105; Test Name: COVID test; Test Result: Negative; Comments: Nasal swab.

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: My ear neck; Face got swollen; Still have severe pain on my head; Severe pain in shoulder; Still have sever pain in my arm; Still have sever pain on my leg only on right side of body; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 at 09:45(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included type I diabetes, high blood pressure, epilepsy, pancreatitis and known allergies to penicillin, sea shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin (MANUFACTURER UNKNOWN) and buprenorphine (BUTRANS) patches; both for an unknown indication from unknown date and unknown if ongoing. On 23Apr2021 at 08:00 the patient experienced his ear neck and face got swollen. Still have severe pain on his head, shoulder and arm and leg only on right side of body. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On 05Nov2020, the patient underwent COVID-19 test (Nasal swab) and the result was negative. The clinical outcome of the events ear neck, face got swollen, severe pain on his head, shoulder and arm and leg only on right side of body was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: INSULIN; BUTRANS.

Current Illness:

ID: 1811395
Sex: M
Age:
State: CA

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210418; Test Name: Body temperature; Result Unstructured Data: Test Result:Mild 102 degree temp; Comments: at 11:00

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Headache; Mild 102 degree temp; Achy; Achy joints; Tired; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 18Apr2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included amlodipine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and benazepril (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 11:00, the patient experienced headache, mild 102 degree (units unspecified) temperature, felt achy, had achy joints and felt tired. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, mild 102 degree (units unspecified) temperature, felt achy, had achy joints and felt tired was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE; HYDROCHLOROTHIAZIDE; BENAZEPRIL

Current Illness:

ID: 1811396
Sex: F
Age:
State: SC

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Sore arm; Achy upper body; Feverish without fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 18Mar2021 at 12:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin d nos (VITAMIN D), cetirizine hydrochloride (ZYRTEC), ethinylestradiol, norethisterone acetate (JUNEL) and multivitamins (MANUFACTURER UNKNOWN), for unknown indications from unknown dates and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 19Mar2021 at 13:00, the patient experienced sore arm for 4 to 5 days, achy upper body, feverish without fever for 3 to 4 hours in 24 hours after first dose and headache for most of the next day after the first dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events sore arm, achy upper body, feverish without fever and headache was recovered on an unknown date in Mar2021. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D [VITAMIN D NOS]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; JUNEL

Current Illness:

ID: 1811397
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Narrowed vision at bedtime; Achy; Weird dreams; Weak; Chills; A little nauseous; Low grade fever; This is a spontaneous report from a contactable consumer. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 19Apr2021 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown, if the patient received any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced narrowed vision at bedtime, little nauseous, low grade fever, weird dreams, chills, weak and achy. The events did not result in doctor or other healthcare professional office or clinic visit or emergency visit. No therapeutic measures were taken as a result of the reported events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events narrowed vision at bedtime, little nauseous, low grade fever, weird dreams, chills, weak and achy were recovered on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811398
Sex: F
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Next morning woke up with numbness in hands and legs; Severe body chills; Shakes; Whole body hurt and body aches all over; Fever the night of vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 08:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 23:30, the night of vaccine, the patient experienced fever. On 17Apr2021, next morning, the patient woke up with numbness in hands and legs, severe body chills, shakes and whole body hurt and body aches all over. All side effects lasted until the next morning and were all gone at the same time. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, numbness in hands and legs, chills, shakes and whole body hurt and body aches all over were resolved on 18Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811399
Sex: F
Age:
State: MA

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Chills; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient . A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 22Apr2021 at 00:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 31Mar2021 at 13:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 00:00, the patient experienced 5 hours of chills, another 8 hours of fever and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills was resolved on 22Apr2021 at 06:00; while that of fever and headache was resolved on 22Apr2021 at 09:00. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811400
Sex: F
Age:
State: FL

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Experienced numbness; Pain through armpit and shoulder; Pain through armpit; Extreme fatigue for 7 days after injection; Left arm where vaccine was injected was extremely painful/ Pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4; Limited mobility on day 1 and 2.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to red wine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 17Apr2021 at 16:00, the patient experienced extreme pain in left arm where vaccine was injected was and had limited mobility on day 1 and 2 (17Apr2021-19Apr2021). The patient also experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 (19Apr2021- 20Apr2021) and extreme fatigue for 7 days after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of reported events which included treatment paracetamol (TYLENOL) and sleep. The clinical outcome of the events extreme fatigue was recovered on 24Apr2021, after the duration of 7 days. The clinical outcome of events left arm where vaccine was injected was extremely painful and had limited mobility on day 1 and 2, experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 and extreme fatigue was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811401
Sex: F
Age:
State:

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Patient reports feeling symptoms oflow blood sugar the day after thevaccination; strange taste; Strange smell; This is a spontaneous report from a non-contactable pharmacist. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 15Apr2021 at 08:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD). The patient did not have a history of allergies to medications, food, or other products. Concomitant medications included omeprazole (PRILOSEC) from unknown date and for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced strange taste and smell which started about 24 hours after the vaccine and lasted for about 48 hours. On 16Apr2021, the patient reported feeling symptoms of low blood sugar the day after the vaccination, despite having eaten normally. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strange taste and smell was resolved on 17Apr2021, after the duration of 24 hours (and 48 hours after vaccination). The clinical outcome of the event feeling symptoms of low blood sugar was resolved on an unknown date at Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PRILOSEC [OMEPRAZOLE]

Current Illness:

ID: 1811402
Sex: M
Age:
State: MD

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Nausea; Stomach pains/. stomach pains have gotten much worse; Major headache; Body aches; Fatigue; Had typical arm sore; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Apr2021, next morning, the patient experienced typical arm sore then had diarrhea and the patient was good for next 2 days. On 17Apr2021, the patient woke up on Saturday with a major headache then as the day went on body aches and fatigue set in. On 19Apr2021, Monday the patient had started getting stomach pains. On 20Apr2021 (reported as today), the stomach pains had gotten much worse leading to diarrhea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was taken as a result of the headache which included paracetamol (TYLENOL) every 8 hours to control headache and for other events was not taken. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event typical arm sore was resolved on an unknown date in Apr2021; whereas for the events diarrhea, major headache, body aches, fatigue, stomach pains and nausea was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811403
Sex: M
Age:
State: TX

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Severe headache; Chills; Fever (fever dropped after 2 days); Nausea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 14:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included appendectomy. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021 at 03:00, the patient experienced severe headache, chills, fever and nausea which lasted about 4-5 days (fever dropped after 2 days). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, chills, fever (fever dropped after 2 days) and nausea was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811404
Sex: F
Age:
State: WI

Vax Date: 03/09/2021
Onset Date: 03/11/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: With both vaccines around 2 days later got two cold sores with each; This is a spontaneous report from a contactable nurse, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Mar2021 at 15:00 (at the age of 24-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included Attention Deficit Hyperactivity Disorder (ADHD) and migraines. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) and spironolactone (MANUFACTURER UNKNOWN), both taken for an unspecified indication from an unknown date and unknown if ongoing. On 11Mar2021 at 13:00 and 08Apr2021, two days after the administration of both the doses, the patient got two cold sores with each. She did not have a break out in over two years and had been very careful and kept her schedule/diet/health the same. The one difference both times was with the vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with valacyclovir (MANUFACTURER UNKNOWN) medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event cold sores was recovering at the time of report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VYVANSE; SPIRONOLACTONE

Current Illness:

ID: 1811405
Sex: F
Age:
State: UT

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Severe chills; Fever; Extreme nausea; Headache; Severe body aches; Agitation; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (CLARITIN) for allergies from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 01:30, the patient experienced severe chills, fever, extreme nausea, headache, severe body aches, agitation and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe chills, fever, extreme nausea, headache, severe body aches, agitation and extreme fatigue was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CLARITIN [LORATADINE]

Current Illness:

ID: 1811406
Sex: F
Age:
State: IA

Vax Date: 03/26/2021
Onset Date: 03/28/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Dose 1:10Mar2021, Dose2: 26Mar2021 (duration between the doses is 16 days); Itchy rash from injection site to elbow; This is a spontaneous report from a non-contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation (inappropriate schedule of vaccine administered). Medical history was included known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 08:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 28Mar2021 within couple of days, the patient experienced itchy rash from injection site to elbow which lasted for 2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event, itchy rash from injection site to elbow was resolved on an unknown date in Apr 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEXAPRO

Current Illness:

ID: 1811407
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Severe leg cramping; So bad could not walk; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 13:45 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not take any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received rosuvastatin calcium (CRESTOR) for unknown indication on an unknown date and experienced drug allergy. On 16Apr2021 at 17:00, the patient experienced severe leg cramping, so bad could not walk. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included unspecified medication for muscle spasms. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe leg cramping, so bad could not walk was resolved on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811408
Sex: F
Age:
State: NJ

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Left arm broke out into mild hives; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to some antibiotics. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication within 2 weeks of vaccination. The patient previously received azithromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 19Apr2021 at 19:30, 12 hours after vaccination, the patient experienced that her left arm broke out into mild hives. The hives cleared up by the next morning. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hives was recovered on 20Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811409
Sex: F
Age:
State: NY

Vax Date: 04/19/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Rash appeared from both wrists to about half of the arm. It doesn't hurt or itchy.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0151) via an unspecified route of administration in the left arm on 19Apr2021 at 15:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included hydrochlorothiazide, losartan potassium (LOSARTAN/HCTZ) and thiamazole (METHIMAZOLE) for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 22Mar2021 at 15:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. On 22Apr2021, the patient experienced rash which appeared from both wrists to about half of the arm. It didn't hurt or itchy. The clinical outcome of the event rash appeared from both wrists to about half of the arm. It didn't hurt or itchy was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN/HCTZ; METHIMAZOLE

Current Illness:

ID: 1811410
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Itching of the injection site; Severe headache; Fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 at 14:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 00:00, the patient experienced itching of the injection site, severe headache, fever and body aches. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itching of the injection site, severe headache, fever, body aches were not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811411
Sex: F
Age:
State: IL

Vax Date: 04/21/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: both hands were red; both hands were very pale white; Both hands felt very numb; Both hands were tingling; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 10:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included gilberts syndrome 10 years ago and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included acetylsalicylic acid(ALKA SELTZER) from an unknown date for an unknown indication and unknown if ongoing. On 24Apr2021 at 07:00 the patients both hands were red and very pale white, felt very numb and tingling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events which included treatment with anti inflammatory drugs. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events both hands were red and very pale white, felt very numb and tingling were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ALKA-SELTZER

Current Illness:

ID: 1811412
Sex: F
Age:
State: OH

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Extreme migraine; Muscle aches; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 19Apr2021 at 13:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 19Apr2021 at 20:00, the patient experienced extreme migraine and muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme migraine and muscle aches was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811413
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: "I" began tinnitus in "my" right ear and dizziness.; "I" began tinnitus in "my" right ear and dizziness.; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Apr2021 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 10Apr2021, the day after her second dose of the vaccine, the patient experienced tinnitus in her right ear and dizziness. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tinnitus in her right ear and dizziness was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811414
Sex: F
Age:
State: AL

Vax Date: 04/09/2021
Onset Date: 04/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: A swollen, sore spot appeared in the left armpit; Large and painful swollen lymph node; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, days after receiving vaccination, the patient experienced a swollen, sore spot that appeared in the left armpit. It was reported that the spot had continued to swell, and it was then very, very painful and continued to grow and it was then nearly the size of half a golf ball. She had been told that it looked like a swollen lymph node, but was shocked at how large and painful it was. The fact that it continued to grow in size concerned her. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events a swollen, sore spot appeared in the left armpit was and large and painful swollen lymph node was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811415
Sex: F
Age:
State: LA

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Ears have been ringing loudly 24 hours a day; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), ibuprofen (ADVIL) and diphenhydramine hydrochloride (BENADRYL); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 20:00, the patient's ears had been ringing loudly 24 hours a day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ears have been ringing loudly 24 hours a day was not resolved at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: WELLBUTRIN; ADVIL [IBUPROFEN]; BENADRYL

Current Illness:

ID: 1811416
Sex: F
Age:
State: NC

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Extreme vertigo; Debilitating; Dizziness; Feels like electrical zaps in my brain; Difficult to think clearly or move; Difficult to think clearly or move; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 03Apr2021 at 10:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and attention deficit-hyperactivity disorder (ADHD). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 04Apr2021 at 08:00, the patient experienced extreme vertigo, debilitating dizziness-feels like electrical zaps in brain that make it difficult to think clearly or move. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme vertigo, debilitating dizziness-feels like electrical zaps in brain that make it difficult to think clearly or move were not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811417
Sex: F
Age:
State: OR

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Itchy rash at the injection site; Another rash about an inch away from the main site; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735,) via an unspecified route of administration in the left arm on 15Apr2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 15Apr2021 at 22:00, about 12 hours after the vaccination, the patient experienced itchy rash at the injection site and also another rash about an inch away from the main site. The reaction happened about 12 hours after receiving the injection and lasted about 5 days. The patient was wondering if a worse rash could happen when she gets the second shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itchy rash at the injection site and another rash about an inch away from the main site were resolved on 20Apr2021 after a duration of about 5 days. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1811418
Sex: F
Age:
State: MD

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Last night of insomnia, never slept all night. Coincided with brain fog. Did not remember dogs vet visit. Did not check calendar. Did not notice telephone or text reminders. Missed appointment.; Soreness and swelling at injection site.; Soreness and swelling at injection site.; Headache and nausea; Headache and nausea; Extreme fatigue and need to sleep.; Extreme fatigue and need to sleep.; Feeling hot and cold.; Feeling hot and cold.; insomnia; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 74-year-old), as a single dose for COVID-19 immunisation. Medical history included restless leg syndrome, raynaud's syndrome, polio, malaria, gastro oesophageal reflux disease (GERD), removed thyroid, removed pituitary tumor (ended migraine headaches of 30 years), known allergy to penicillin, concord grapes and must not take NSAIDs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN), pramipexole dihydrochloride monohydrate (MIRAPEX) and colecalciferol (VITAMIN D3) and Al (as reported); for unknown indication from an unknown date and unknown if ongoing. The patient previously received metronidazole(FLAGYL) and prochlorperazine edisylate(COMPAZINE) both for unknown indication from an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 10Mar2021 at 15:15 (at the age of 74-year-old), as a single dose for COVID-19 immunisation. On 31Mar2021 at 17:30, the patient experienced soreness and swelling at injection site, headache, nausea and extreme fatigue and need to sleep, felt hot and cold. The patient had early reactions in first few days. The patient then got better and then extreme fatigue returned and was unable to do more than 3 tasks in a day. It was reported that if the patient did more, had to rest 2 days. On an unknown date in 2021, most recently the patient had insomnia, for 5 of 7 nights unable to sleep except for 2 hours at end of usual sleep time. The patient never had insomnia in her life before. On unknown date of Apr2021 (reported as last night) patient had insomnia, never slept all night, coincided with brain fog and did not remember dog's vet visit, did not check calendar, did not notice telephone or text reminders and missed appointment. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness and swelling at injection site, headache, nausea and extreme fatigue and need to sleep, felt hot and cold, brain fog, insomnia, was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXINE; DULOXETINE; MIRAPEX; VITAMIN D3

Current Illness:

ID: 1811419
Sex: F
Age:
State: WA

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Sore arm; Nausea; Fatigue; Muscle aches; Fever; Sore throat; Headache; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm right on 19Apr2021 at 14:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included crohn's disease, panic disorder and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ustekinumab (STELARA), alprazolam (XANAX) and ritual vitamins (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received clindamycin palmitate hydrochloride (CLINDAMYCIN) and ceftriaxone sodium (ROCEPHIN) and experienced drug allergy. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 24Mar2021 at 15:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 16:00, the patient experienced sore arm, nausea, fatigue, muscle aches, fever, sore throat, headache and dizziness. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, nausea, fatigue, muscle aches, fever, sore throat, headache and dizziness was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: STELARA; XANAX

Current Illness:

ID: 1811420
Sex: F
Age:
State: FL

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210420; Test Name: Nasal Swab; Result Unstructured Data: Test Result:UNKNOWN RESULTS

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Strong headache; Muscle pain; Dizzing; arm pain; chills; join pain; nausea; tiredness; rash; itching; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 17Apr2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and known allergies were reported as n/a. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included fish oil (OMEGA 3), ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN),all for unknown indications from unknown dates and unknown if ongoing. On 18Apr2021 at 01:00, the patient experienced chills, nausea, strong headache, muscle pain, dizzing, arm pain, join pain, tiredness, rash and itching. On 20Apr2021, the patient underwent SARS-CoV-2 nasal swab test and the result was unknown. The adverse events did not result in doctor or other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events chills, nausea, strong headache, muscle pain, dizzing, arm pain, join pain, tiredness, rash and itching were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; ZINC; OMEGA 3 [FISH OIL]

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am